|
Exchange Received Time  04/02/2019 16:22:40 Exchange Disseminated Time 04/02/2019 16:22:43 Time Taken 00:00:03 | LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine-Months Ended on December 31, 2018 along with any other business, if any. |
|
|